Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tevogen Bio Holdings Inc. - Common Stock
(NQ:
TVGN
)
1.720
+0.340 (+24.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
101,268,150
Open
1.610
Bid (Size)
1.760 (1)
Ask (Size)
1.790 (4)
Prev. Close
1.380
Today's Range
1.560 - 2.190
52wk Range
0.2556 - 21.09
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
October 18, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
October 18, 2024
Via
Benzinga
Performance
YTD
-82.80%
-82.80%
1 Month
+290.91%
+290.91%
3 Month
+122.31%
+122.31%
6 Month
+2.99%
+2.99%
1 Year
-82.80%
-82.80%
More News
Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 17, 2024
Via
Benzinga
Why Is Small-Cap Tevogen Bio Stock Rocketing Higher On Thursday?
October 17, 2024
Via
Benzinga
Exposures
COVID-19
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
October 17, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion
October 17, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality
October 16, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 15, 2024
Via
Benzinga
Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions
October 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Highlights the Publication of Promising Trial Data as the CEO Expresses Optimism About the Company’s Scientific Breakthrough in Mainstreaming Cell Therapy Through a New Class of Off-the-Shelf T-Cell Therapies, Manufactured and Stored for
October 15, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
October 15, 2024
Via
Benzinga
Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections
October 14, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump
October 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
October 14, 2024
Via
Benzinga
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher
October 14, 2024
Via
Benzinga
Exposures
Fossil Fuels
Leaders in The News: BigBear.ai, Luminar, New World Solutions, Tevogen Bio
October 14, 2024
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction
October 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 14, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
October 14, 2024
Via
Benzinga
A Lot Of Home Runs And One Ugly Strikeout; One New Swing Position
October 12, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
October 11, 2024
Via
Benzinga
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
October 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
October 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.